Publication | Open Access

Overall Survival Improvement in Patients with Lung Cancer and Bone Metastases Treated with Denosumab Versus Zoledronic Acid: Subgroup Analysis from a Randomized Phase 3 Study

MedicineCancer ManagementClinical TrialsRandomized Phase 3Cancer TreatmentOncologyRadiation OncologyOsteoporosisLung CancerOverall Survival ImprovementHealth Sciences